Stifel lowered the firm’s price target on Colgate-Palmolive (CL) to $95 from $101 and keeps a Hold rating on the shares. The firm updated and ...

Colgate-Palmolive (NYSE:CL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the twenty-two ...

We recently published a list of 10 Best Dividend Kings Stocks to Invest in Now. In this article, we are going to take a look ...

Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $87.67 which represents a slight increase of $0.57 or 0.65% from the prior close of $87.1. The stock opened at $87.21 and touched ...

Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...

Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, ...

Graypoint LLC raised its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 16.4% during the 4th quarter, ...

On the other hand, Colgate-Palmolive has seen better revenue growth over the recent quarters and is trading at a relatively lower valuation. Now, looking at prospects, using P/S as a base ...

Colgate-Palmolive Co. closed $22.20 short of its 52-week high ($109.30), which the company reached on September 5th.

New York-based Colgate-Palmolive Company (CL) is a global leader in the oral care hygiene market. It produces and distributions household, healthcare and personal care products. With a market cap ...